The NIH Clinical Center is a hospital solely dedicated to clinical research at the National Institutes of Health campus in Bethesda, Maryland.

During the past decade, Mark O Hatfield-Warren Grant Magnuson Clinical Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mark O Hatfield-Warren Grant Magnuson Clinical Center" #1 collaborator was "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Mark O Hatfield-Warren Grant Magnuson Clinical Center" are "Unspecified Childhood Solid Tumor, Protocol Specific" (3 trials), "Post-transplant Lymphoproliferative Disorder" (2 trials), "Prader-Willi Syndrome" (2 trials), "Primary Central Nervous System Non-Hodgkin Lymphoma" (2 trials) and "Recurrent Grade 1 Follicular Lymphoma" (2 trials). Many other conditions were trialed in "Mark O Hatfield-Warren Grant Magnuson Clinical Center" in a lesser frequency.

Most popular intervention types in "Mark O Hatfield-Warren Grant Magnuson Clinical Center" are "Drug" (10 trials), "Other" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "laboratory biomarker analysis" (4 trials), "pharmacological study" (4 trials), "DCCR" (2 trials), "Placebo for DCCR" (2 trials) and "Setmelanotide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Mark O Hatfield-Warren Grant Magnuson Clinical Center" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Mark O Hatfield-Warren Grant Magnuson Clinical Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 8 completed trials in Mark O Hatfield-Warren Grant Magnuson Clinical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mark O Hatfield-Warren Grant Magnuson Clinical Center, 4 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".